ADAR1, FLAG-Tag Recombinant

• Background:

  ADAR1 (adenosine deaminase, RNA-specific 1) performs adenosine to inosine base editing in RNA, particularly targeting adenosines located within a specific stem-loop motif structure. It is proposed that ADARs evolved to provide additional diversity to the transcriptome and while the majority of ADAR editing events occur in non-coding RNAs, some, including the canonical GluA2 editing site, alter the amino acid sequence of coding proteins. ADAR1 plays a role in innate immunity by mitigating interferon signaling. Dysfunction of ADAR1 results in autoimmune disorders, and impacts cancer cell growth and proliferation as well as tumor response to immunotherapy. Since ADAR recognizes double-stranded RNA, it also functions to suppress or modify RNA viruses. Thus, it is implicated in viral evolution and in the emergence of viral variants such as SARS-CoV-2 variants.

• Description:

  Recombinant human ADAR1 (adenosine deaminase, RNA-specific 1) transcript 1, full length encompassing amino acids 2-1226 (end) . This construct contains an N-terminal FLAG-tag. The recombinant protein was affinity purified.

• UniProt:

  P55265

• Tag:

  N-terminal FLAG-tag

• Purity:

  ≥ 70%

• Format:

  Aqueous buffer solution

• Shipping Conditions:

  -80°C

• Storage Conditions:

  At least 6 months at –80°C.

• Calculated Molecular Weight:

  137 kDa

• Formulation:

  50 mM Tris-HCl, pH 8.0,750 mM NaCl, 0.01% Triton X-100,10% glycerol and variable FLAG peptide.